• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

• M
• Malhotra, Jasnoor
  City of Hope Comprehensive Cancer Center
• 10: Waning efficacy of COVID-19 vaccination at 6 months in patients with renal cell carcinoma (RCC)
  Jasnoor Malhotra
  Favorite
• Meza Contreras, Luis
  City of Hope Comprehensive Cancer Center
• 25: Ultra-sensitive circulating tumor DNA (ctDNA) assay distinguishes partial response (PR) and complete response (CR) with immunotherapy in metastatic renal cell carcinoma (mRCC)
  Luis Meza Contreras
  Favorite
• Motzer, Robert
  Memorial Sloan Kettering Cancer Center
• 22: Characterization and Management of Adverse Reactions in Patients With Advanced Renal Cell Carcinoma Receiving Lenvatinib + Pembrolizumab (CLEAR Study)
  Robert Motzer
  Favorite
• 29: LITESPARK-011: Belzutifan Plus Lenvatinib Versus Cabozantinib: A Randomized, Open-Label Phase 3 Study in Patients With Advanced Renal Cell Carcinoma (RCC) After Anti–PD-1/PD-L1 Therapy
  Robert Motzer
  Favorite